Insight Advisors LLC PA Sells 2,996 Shares of ARK Genomic Revolution ETF (BATS:ARKG)

Insight Advisors LLC PA reduced its holdings in ARK Genomic Revolution ETF (BATS:ARKG) by 17.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 14,237 shares of the company’s stock after selling 2,996 shares during the period. Insight Advisors LLC PA’s holdings in ARK Genomic Revolution ETF were worth $338,000 as of its most recent SEC filing.

A number of other large investors also recently modified their holdings of the business. Wealthcare Advisory Partners LLC boosted its stake in ARK Genomic Revolution ETF by 2.8% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 15,903 shares of the company’s stock worth $374,000 after buying an additional 435 shares in the last quarter. Crescent Grove Advisors LLC lifted its holdings in shares of ARK Genomic Revolution ETF by 1.6% during the 3rd quarter. Crescent Grove Advisors LLC now owns 28,914 shares of the company’s stock worth $740,000 after acquiring an additional 460 shares during the period. National Bank of Canada FI boosted its position in shares of ARK Genomic Revolution ETF by 28.4% during the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock valued at $106,000 after acquiring an additional 920 shares in the last quarter. Brown Miller Wealth Management LLC increased its stake in ARK Genomic Revolution ETF by 5.5% in the third quarter. Brown Miller Wealth Management LLC now owns 17,974 shares of the company’s stock valued at $460,000 after acquiring an additional 933 shares during the period. Finally, Dynamic Advisor Solutions LLC raised its position in ARK Genomic Revolution ETF by 7.8% in the third quarter. Dynamic Advisor Solutions LLC now owns 13,590 shares of the company’s stock worth $348,000 after purchasing an additional 989 shares in the last quarter.

ARK Genomic Revolution ETF Price Performance

Shares of ARKG opened at $27.34 on Friday. The business’s 50 day simple moving average is $25.40 and its 200-day simple moving average is $25.23.

ARK Genomic Revolution ETF Profile

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.